News

EVOQ Therapeutics Secures $2 Million in Funding for Advanced Autoimmune NanoDisc Therapies

Ann Arbor, MI and Chicago, IL – August 29, 2024 – EVOQ Therapeutics, Inc. (EVOQ) a biopharmaceutical company dedicated to the treatment...

Aug 15, 20242 min read

37 views

0 comments

Gilead and EVOQ Therapeutics Announce Collaboration to Advance Immunotherapies

Gilead Receives Rights to Exclusively License EVOQ’s NanoDisc Technology to Develop and Commercialize Immunotherapy Products for...

Jan 18, 20233 min read

28 views

0 comments

EVOQ Announces Breakthrough T1D (Formerly JDRF) Collaboration to Develop its Novel Platform Technology in Type 1 Diabetes

ANN ARBOR, Mich., December 13, 2022 – EVOQ Therapeutics , Inc. (EVOQ), a biopharmaceutical company focused on the discovery and...

Dec 12, 20222 min read

11 views

0 comments

EVOQ Therapeutics Expands Leadership Team with David Giljohann, Ph.D., as Chief Executive Officer and Greg Barrett as Chief Operating Officer

ANN ARBOR, Mich., January 9, 2023 – EVOQ Therapeutics, Inc. (EVOQ), a biopharmaceutical company focused on the discovery and development...

Jan 9, 20222 min read

7 views

0 comments

Contact Us

Have questions or want to learn more about our work? We’d love to hear from you! Whether you're a potential partner, researcher, or someone interested in our therapies, we're here to connect. Reach out to us and let’s start the conversation.

1600 Huron Parkway
Bldg 420, 2nd Floor
Ann Arbor, Michigan 48109

info@evoqtherapeutics.com